Letter: faecal calprotectin for the prediction of relapse in inactive inflammatory bowel disease - authors' reply
Aliment Pharmacol Ther
.
2016 Oct;44(7):770-1.
doi: 10.1111/apt.13767.
Authors
Y Zhulina
1
,
Y Cao
2
3
,
K Amcoff
4
5
,
M Carlson
5
,
C Tysk
4
,
J Halfvarson
4
Affiliations
1
Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
[email protected]
.
2
Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.
3
Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
4
Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
5
Department of Medical Sciences, Gastroenterology Research Group, Uppsala University, Uppsala, Sweden.
PMID:
27593429
DOI:
10.1111/apt.13767
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers
Feces
Humans
Inflammatory Bowel Diseases*
Leukocyte L1 Antigen Complex*
Recurrence
Substances
Biomarkers
Leukocyte L1 Antigen Complex